Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07376226 · ClinicalTrials.gov registry record · NA
Effects of Whole Fruit on Blood Sugar in People With Type 2 Diabetes
A NA study, sponsored by Harvard School of Public Health (HSPH).
- Not yet
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT07376226: Clinical Trial NA study, sponsored by Harvard School of Public Health (HSPH).
NCT07376226 is a NA study that has not yet begun recruiting, run by Harvard School of Public Health (HSPH). The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07376226, a NA study, has not yet begun recruiting, sponsored by Harvard School of Public Health (HSPH).
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study will determine the effects of consuming whole fruit on blood sugar control, liver fat, and cardiovascular health in adults with type 2 diabetes who are not treated with insulin.
Primary Outcome
Average 24-hour interstitial glucose levels (mg/dl), as measured by continuous glucose monitoring (CGM). If needed, data will be adjusted for any changes in antihyperglycemic medication use, using the medication effect score (MES).
Interventions
- OTHER Whole Fruit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-09 |
| Est. Completion | 2028-04 |
| Phase | NA |
What is known before NCT07376226 opens enrollment
NCT07376226 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Whole Fruit is the first listed.
NCT07376226 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07376226 about?
NCT07376226 is a clinical study titled "Effects of Whole Fruit on Blood Sugar in People With Type 2 Diabetes". This study will determine the effects of consuming whole fruit on blood sugar control, liver fat, and cardiovascular health in adults with type 2 diabetes who are not treated with insulin.
What is the current status of trial NCT07376226?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2026-09. Estimated completion is 2028-04.
What interventions are being tested in trial NCT07376226?
The interventions under investigation include: Whole Fruit (OTHER).
Who is sponsoring clinical trial NCT07376226?
This trial is sponsored by Harvard School of Public Health (HSPH), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07376226's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia